Delayed Diagnosis Salicylate Toxicity With Confirmed Cerebrospinal Fluid Salicylate Concentration: A Case Report of Altered Mental Status Without Neuroglycopenia and With Coagulopathy

Salicylate toxicity usually occurs as a result of elevated serum salicylate concentrations. Salicylate concentrations can be measured in cerebrospinal fluid (CSF), but the interpretation of these values is less well understood. Two phenomena believed to be associated with salicylate toxicity are neuroglycopenia and salicylate-induced coagulopathy, but these cases are typically not well-characterized. We report a case of delayed diagnosis of salicylate toxicity that was complicated by coagulopathy and had a quantifiable CSF salicylate concentration. An 18-year-old female patient presented with abdominal pain and an altered mental state; she had previously presented at another hospital one day prior. She did not initially report salicylate overdose. A lumbar puncture was performed 4.5 hours after emergency department (ED) presentation to rule out meningitis. Due to additional history, a serum salicylate concentration obtained at 25 hours led to a result of 48.8 mg/dL (therapeutic range: 15-30 mg/dL). Hemodialysis (HD) was performed 37 hours after ED presentation due to the altered mental state. Prior to HD, the patient had a prothrombin time of 63 seconds (reference range: 11-13 seconds), international normalized ratio of 5.52 (reference range: 0.8-1.1), and activated partial thromboplastin time of 40.2 seconds (reference range: 25-35 seconds). After the case conclusion, waste CSF was tested and the CSF salicylate concentration was 23 mg/dL; the corresponding CSF and serum glucose concentrations were 60 mg/dL (reference range: 50-75 mg/dL) and 87 mg/dL (reference range: 70-99 mg/dL), respectively. This is a case of delayed diagnosis salicylate poisoning complicated by coagulopathy, without neuroglycopenia. Although we do not recommend routine CSF testing in salicylate toxicity cases, analysis of CSF could shed insight into salicylate-induced encephalopathy. This case illustrates that prompt recognition and treatment of toxicity is key, as delayed diagnosis can increase morbidity and mortality.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-08-08
DOI
https://doi.org/10.7759/cureus.89613
Primary Topic
Poisoning and overdose treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Delayed Diagnosis Salicylate Toxicity With Confirmed Cerebrospinal Fluid Salicylate Concentration: A Case Report of Altered Mental Status Without Neuroglycopenia and With Coagulopathy

Joshua Bloom, Rana Biary, Mallika Singh, Mark K. Su et al.
Cureus
Poisoning and overdose treatments
article

Delayed Diagnosis Salicylate Toxicity With Confirmed Cerebrospinal Fluid Salicylate Concentration: A Case Report of Altered Mental Status Without Neuroglycopenia and With Coagulopathy

Joshua Bloom, Rana Biary, Mallika Singh, Mark K. Su, Mary Ann Howland
article en

Abstract

Salicylate toxicity usually occurs as a result of elevated serum salicylate concentrations. Salicylate concentrations can be measured in cerebrospinal fluid (CSF), but the interpretation of these values is less well understood. Two phenomena believed to be associated with salicylate toxicity are neuroglycopenia and salicylate-induced coagulopathy, but these cases are typically not well-characterized. We report a case of delayed diagnosis of salicylate toxicity that was complicated by coagulopathy and had a quantifiable CSF salicylate concentration. An 18-year-old female patient presented with abdominal pain and an altered mental state; she had previously presented at another hospital one day prior. She did not initially report salicylate overdose. A lumbar puncture was performed 4.5 hours after emergency department (ED) presentation to rule out meningitis. Due to additional history, a serum salicylate concentration obtained at 25 hours led to a result of 48.8 mg/dL (therapeutic range: 15-30 mg/dL). Hemodialysis (HD) was performed 37 hours after ED presentation due to the altered mental state. Prior to HD, the patient had a prothrombin time of 63 seconds (reference range: 11-13 seconds), international normalized ratio of 5.52 (reference range: 0.8-1.1), and activated partial thromboplastin time of 40.2 seconds (reference range: 25-35 seconds). After the case conclusion, waste CSF was tested and the CSF salicylate concentration was 23 mg/dL; the corresponding CSF and serum glucose concentrations were 60 mg/dL (reference range: 50-75 mg/dL) and 87 mg/dL (reference range: 70-99 mg/dL), respectively. This is a case of delayed diagnosis salicylate poisoning complicated by coagulopathy, without neuroglycopenia. Although we do not recommend routine CSF testing in salicylate toxicity cases, analysis of CSF could shed insight into salicylate-induced encephalopathy. This case illustrates that prompt recognition and treatment of toxicity is key, as delayed diagnosis can increase morbidity and mortality.

CureusVol. 17(8)
New York City Department of Health and Mental Hygiene (US), St. John's University (US), Jacobi Medical Center (US), St. John's University (TW), Jamaica Hospital (US), New York University (US)
Good health and well-being, Zero hunger
Openalex Percentile: Top 68%
Poisoning and overdose treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.